{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:54:17Z","timestamp":1794434057161,"version":"4.9.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2023AFB712"],"award-info":[{"award-number":["2023AFB712"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2022CFB883"],"award-info":[{"award-number":["2022CFB883"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072805"],"award-info":[{"award-number":["82072805"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203879"],"award-info":[{"award-number":["82203879"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Glioma stem-like cells (GSCs) are key drivers of treatment resistance and recurrence in glioblastoma (GBM). Phosphoglycerate dehydrogenase (PHGDH), a crucial enzyme in the de novo serine synthesis pathway (SSP), is implicated in tumorigenesis and therapy resistance across various cancers. However, its specific role in GBM, particularly in radioresistance, remains poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In silico analysis of GBM patient data assessed SSP enrichment and PHGDH expression linked with tumor stemness. Comparative gene expression analysis focused on PHGDH in paired GBM specimens and GSCs. Genetic and pharmacological loss-of-function assays were performed in vitro and in vivo to evaluate PHGDH\u2019s impact on GSC self-renewal and malignant progression. Comprehensive transcriptomic and metabolomic analyses, along with chromatin immunoprecipitation, mass spectrometry, and various other biochemical assays, were used to elucidate PHGDH-mediated mechanisms in GBM progression and radioresistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>PHGDH expression is significantly elevated in GSCs, associated with aggressive glioma progression and poor clinical outcomes. PHGDH activation enhances GSC self-renewal by regulating redox homeostasis, facilitating one-carbon metabolism, and promoting DNA damage response via SSP activation. Importantly, MYC was identified as a crucial transcriptional regulator of PHGDH expression. Furthermore, genetic ablation or pharmacological inhibition of PHGDH markedly reduced tumor growth and increased tumor sensitivity to radiotherapy, thereby improving survival outcomes in orthotopic GSC-derived and patient-derived GBM xenograft models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study underscores the pivotal role of MYC-mediated PHGDH activation in driving GSC malignant progression and radioresistance in GBM. Targeting PHGDH presents a promising approach to enhance radiotherapy efficacy in GBM patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-025-03361-3","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T22:21:16Z","timestamp":1742336476000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["PHGDH activation fuels glioblastoma progression and radioresistance via serine synthesis pathway"],"prefix":"10.1186","volume":"44","author":[{"given":"Xiaojin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiasheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojie","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suojun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghong","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haohao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"issue":"5","key":"3361_CR1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459\u201366.","journal-title":"Lancet Oncol"},{"key":"3361_CR2","doi-asserted-by":"crossref","unstructured":"Tan AC, Ashley DM, Lopez GY, Malinzak M, Friedman HS, Khasraw M. Management of glioblastoma: State of the art and future directions. CA Cancer J Clin. 2020;70(4):299\u2013312.","DOI":"10.3322\/caac.21613"},{"issue":"4","key":"3361_CR3","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","volume":"178","author":"C Neftel","year":"2019","unstructured":"Neftel C, Laffy J, Filbin MG, Hara T, Shore ME, Rahme GJ, Richman AR, Silverbush D, Shaw ML, Hebert CM, et al. An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell. 2019;178(4):835-849 e821.","journal-title":"Cell"},{"issue":"7120","key":"3361_CR4","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nature05236","volume":"444","author":"S Bao","year":"2006","unstructured":"Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444(7120):756\u201360.","journal-title":"Nature"},{"issue":"9","key":"3361_CR5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41568-022-00486-x","volume":"22","author":"RC Gimple","year":"2022","unstructured":"Gimple RC, Yang K, Halbert ME, Agnihotri S, Rich JN. Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity. Nat Rev Cancer. 2022;22(9):497\u2013514.","journal-title":"Nat Rev Cancer"},{"issue":"11\u201312","key":"3361_CR6","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1101\/gad.324301.119","volume":"33","author":"RC Gimple","year":"2019","unstructured":"Gimple RC, Bhargava S, Dixit D, Rich JN. Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer. Genes Dev. 2019;33(11\u201312):591\u2013609.","journal-title":"Genes Dev"},{"issue":"1","key":"3361_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metab. 2016;23(1):27\u201347.","journal-title":"Cell Metab"},{"issue":"3","key":"3361_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","volume":"21","author":"PS Ward","year":"2012","unstructured":"Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell. 2012;21(3):297\u2013308.","journal-title":"Cancer Cell"},{"issue":"4","key":"3361_CR9","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cmet.2011.07.014","volume":"14","author":"JW Locasale","year":"2011","unstructured":"Locasale JW, Cantley LC. Metabolic flux and the regulation of mammalian cell growth. Cell Metab. 2011;14(4):443\u201351.","journal-title":"Cell Metab"},{"issue":"5930","key":"3361_CR10","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029\u201333.","journal-title":"Science"},{"issue":"12","key":"3361_CR11","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/ng.3421","volume":"47","author":"GM DeNicola","year":"2015","unstructured":"DeNicola GM, Chen PH, Mullarky E, Sudderth JA, Hu Z, Wu D, Tang H, Xie Y, Asara JM, Huffman KE, et al. NRF2 regulates serine biosynthesis in non-small cell lung cancer. Nat Genet. 2015;47(12):1475\u201381.","journal-title":"Nat Genet"},{"issue":"7360","key":"3361_CR12","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10350","volume":"476","author":"R Possemato","year":"2011","unstructured":"Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K, Sethumadhavan S, Woo HK, Jang HG, Jha AK, et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature. 2011;476(7360):346\u201350.","journal-title":"Nature"},{"issue":"5","key":"3361_CR13","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1158\/2159-8290.CD-20-1211","volume":"11","author":"P Dey","year":"2021","unstructured":"Dey P, Kimmelman AC, DePinho RA. Metabolic codependencies in the tumor microenvironment. Cancer Discov. 2021;11(5):1067\u201381.","journal-title":"Cancer Discov"},{"issue":"6487","key":"3361_CR14","doi-asserted-by":"publisher","first-page":"eaaw5473","DOI":"10.1126\/science.aaw5473","volume":"368","author":"B Faubert","year":"2020","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020;368(6487):eaaw5473.","journal-title":"Science"},{"issue":"12","key":"3361_CR15","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1002\/ijc.34353","volume":"152","author":"W Sun","year":"2023","unstructured":"Sun W, Zhao E, Cui H. Target enzymes in serine-glycine-one-carbon metabolic pathway for cancer therapy. Int J Cancer. 2023;152(12):2446\u201363.","journal-title":"Int J Cancer"},{"issue":"15","key":"3361_CR16","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1158\/0008-5472.CAN-16-0530","volume":"76","author":"D Samanta","year":"2016","unstructured":"Samanta D, Park Y, Andrabi SA, Shelton LM, Gilkes DM, Semenza GL. PHGDH expression is required for mitochondrial redox homeostasis, breast cancer stem cell maintenance, and lung metastasis. Can Res. 2016;76(15):4430\u201342.","journal-title":"Can Res"},{"issue":"1","key":"3361_CR17","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.1038\/s41467-019-12606-7","volume":"10","author":"L Wei","year":"2019","unstructured":"Wei L, Lee D, Law CT, Zhang MS, Shen J, Chin DW, Zhang A, Tsang FH, Wong CL, Ng IO, et al. Genome-wide CRISPR\/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC. Nat Commun. 2019;10(1):4681.","journal-title":"Nat Commun"},{"issue":"11","key":"3361_CR18","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s41422-023-00874-4","volume":"33","author":"YQ Wu","year":"2023","unstructured":"Wu YQ, Zhang CS, Xiong J, Cai DQ, Wang CZ, Wang Y, Liu YH, Wang Y, Li Y, Wu J, et al. Low glucose metabolite 3-phosphoglycerate switches PHGDH from serine synthesis to p53 activation to control cell fate. Cell Res. 2023;33(11):835\u201350.","journal-title":"Cell Res"},{"issue":"3","key":"3361_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s11060-012-1018-x","volume":"111","author":"J Liu","year":"2013","unstructured":"Liu J, Guo S, Li Q, Yang L, Xia Z, Zhang L, Huang Z, Zhang N. Phosphoglycerate dehydrogenase induces glioma cells proliferation and invasion by stabilizing forkhead box M1. J Neurooncol. 2013;111(3):245\u201355.","journal-title":"J Neurooncol"},{"issue":"3","key":"3361_CR20","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.cmet.2023.01.010","volume":"35","author":"D Zhang","year":"2023","unstructured":"Zhang D, Li AM, Hu G, Huang M, Yang F, Zhang L, Wellen KE, Xu X, Conn CS, Zou W, et al. PHGDH-mediated endothelial metabolism drives glioblastoma resistance to chimeric antigen receptor T cell immunotherapy. Cell Metab. 2023;35(3):517-534 e518.","journal-title":"Cell Metab"},{"issue":"1","key":"3361_CR21","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1038\/s41467-021-24108-6","volume":"12","author":"H Huang","year":"2021","unstructured":"Huang H, Zhang S, Li Y, Liu Z, Mi L, Cai Y, Wang X, Chen L, Ran H, Xiao D, et al. Suppression of mitochondrial ROS by prohibitin drives glioblastoma progression and therapeutic resistance. Nat Commun. 2021;12(1):3720.","journal-title":"Nat Commun"},{"issue":"7650","key":"3361_CR22","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nature22056","volume":"544","author":"ODK Maddocks","year":"2017","unstructured":"Maddocks ODK, Athineos D, Cheung EC, Lee P, Zhang T, van den Broek NJF, Mackay GM, Labuschagne CF, Gay D, Kruiswijk F, et al. Modulating the therapeutic response of tumours to dietary serine and glycine starvation. Nature. 2017;544(7650):372\u20136.","journal-title":"Nature"},{"issue":"19","key":"3361_CR23","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.3390\/cancers14194910","volume":"14","author":"X Liu","year":"2022","unstructured":"Liu X, Huang Y, Qi Y, Wu S, Hu F, Wang J, Shu K, Zhang H, Bartsch JW, Nimsky C, et al. The GBM tumor microenvironment as a modulator of therapy response: ADAM8 causes tumor infiltration of tams through HB-EGF\/EGFR-mediated CCL2 expression and overcomes TMZ chemosensitization in glioblastoma. Cancers (Basel). 2022;14(19):4910.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"3361_CR24","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","volume":"173","author":"TM Malta","year":"2018","unstructured":"Malta TM, Sokolov A, Gentles AJ, Burzykowski T, Poisson L, Weinstein JN, Kaminska B, Huelsken J, Omberg L, Gevaert O, et al. Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell. 2018;173(2):338-354 e315.","journal-title":"Cell"},{"key":"3361_CR25","doi-asserted-by":"crossref","unstructured":"Chen L, Qi Q, Jiang X, Wu J, Li Y, Liu Z, Cai Y, Ran H, Zhang S, Zhang C, et al. Phosphocreatine promotes epigenetic reprogramming to facilitate glioblastoma growth through stabilizing BRD2. Cancer Discov. 2024;14(8):1547\u201365.","DOI":"10.1158\/2159-8290.CD-23-1348"},{"issue":"1","key":"3361_CR26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.stem.2017.10.005","volume":"22","author":"J Man","year":"2018","unstructured":"Man J, Yu X, Huang H, Zhou W, Xiang C, Huang H, Miele L, Liu Z, Bebek G, Bao S, et al. Hypoxic induction of vasorin regulates notch1 turnover to maintain glioma stem-like cells. Cell Stem Cell. 2018;22(1):104-118 e106.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"3361_CR27","doi-asserted-by":"publisher","first-page":"e20191340","DOI":"10.1084\/jem.20191340","volume":"217","author":"X Zhan","year":"2020","unstructured":"Zhan X, Guo S, Li Y, Ran H, Huang H, Mi L, Wu J, Wang X, Xiao D, Chen L, et al. Glioma stem-like cells evade interferon suppression through MBD3\/NuRD complex-mediated STAT1 downregulation. J Exp Med. 2020;217(5):e20191340.","journal-title":"J Exp Med"},{"issue":"15","key":"3361_CR28","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/S0960-9822(00)00610-2","volume":"10","author":"TT Paull","year":"2000","unstructured":"Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol. 2000;10(15):886\u201395.","journal-title":"Curr Biol"},{"issue":"1","key":"3361_CR29","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41467-020-20223-y","volume":"12","author":"M Tajan","year":"2021","unstructured":"Tajan M, Hennequart M, Cheung EC, Zani F, Hock AK, Legrave N, Maddocks ODK, Ridgway RA, Athineos D, Suarez-Bonnet A, et al. Serine synthesis pathway inhibition cooperates with dietary serine and glycine limitation for cancer therapy. Nat Commun. 2021;12(1):366.","journal-title":"Nat Commun"},{"issue":"7962","key":"3361_CR30","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41586-023-06061-0","volume":"617","author":"H Yuan","year":"2023","unstructured":"Yuan H, Wu X, Wu Q, Chatoff A, Megill E, Gao J, Huang T, Duan T, Yang K, Jin C, et al. Lysine catabolism reprograms tumour immunity through histone crotonylation. Nature. 2023;617(7962):818\u201326.","journal-title":"Nature"},{"issue":"3","key":"3361_CR31","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3390\/cancers12030580","volume":"12","author":"E Bialopiotrowicz","year":"2020","unstructured":"Bialopiotrowicz E, Noyszewska-Kania M, Kachamakova-Trojanowska N, Loboda A, Cybulska M, Grochowska A, Kopczynski M, Mikula M, Prochorec-Sobieszek M, Firczuk M, et al. Serine biosynthesis pathway supports MYC-miR-494-EZH2 feed-forward circuit necessary to maintain metabolic and epigenetic reprogramming of Burkitt lymphoma cells. Cancers. 2020;12(3):580.","journal-title":"Cancers"},{"issue":"4","key":"3361_CR32","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/cr.2015.33","volume":"25","author":"L Sun","year":"2015","unstructured":"Sun L, Song L, Wan Q, Wu G, Li X, Wang Y, Wang J, Liu Z, Zhong X, He X, et al. cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions. Cell Res. 2015;25(4):429\u201344.","journal-title":"Cell Res"},{"issue":"3","key":"3361_CR33","doi-asserted-by":"publisher","first-page":"e20221524","DOI":"10.1084\/jem.20221524","volume":"220","author":"MR Silvis","year":"2023","unstructured":"Silvis MR, Silva D, Rohweder R, Schuman S, Gudipaty S, Truong A, Yap J, Affolter K, McMahon M, Kinsey C. MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4\/6 and lysosomal inhibition. J Exp Med. 2023;220(3):e20221524.","journal-title":"J Exp Med"},{"issue":"13","key":"3361_CR34","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1016\/j.ejca.2004.02.031","volume":"40","author":"MF Renschler","year":"2004","unstructured":"Renschler MF. The emerging role of reactive oxygen species in cancer therapy. Eur J Cancer. 2004;40(13):1934\u201340.","journal-title":"Eur J Cancer"},{"issue":"7","key":"3361_CR35","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrd2803","volume":"8","author":"D Trachootham","year":"2009","unstructured":"Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. 2009;8(7):579\u201391.","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"3361_CR36","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nchembio.2070","volume":"12","author":"ME Pacold","year":"2016","unstructured":"Pacold ME, Brimacombe KR, Chan SH, Rohde JM, Lewis CA, Swier LJ, Possemato R, Chen WW, Sullivan LB, Fiske BP, et al. A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate. Nat Chem Biol. 2016;12(6):452\u20138.","journal-title":"Nat Chem Biol"},{"issue":"5","key":"3361_CR37","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nn.4537","volume":"20","author":"X Wang","year":"2017","unstructured":"Wang X, Yang K, Xie Q, Wu Q, Mack SC, Shi Y, Kim LJY, Prager BC, Flavahan WA, Liu X, et al. Purine synthesis promotes maintenance of brain tumor initiating cells in glioma. Nat Neurosci. 2017;20(5):661\u201373.","journal-title":"Nat Neurosci"},{"issue":"1","key":"3361_CR38","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1038\/s41467-020-17512-x","volume":"11","author":"W Zhou","year":"2020","unstructured":"Zhou W, Yao Y, Scott AJ, Wilder-Romans K, Dresser JJ, Werner CK, Sun H, Pratt D, Sajjakulnukit P, Zhao SG, et al. Purine metabolism regulates DNA repair and therapy resistance in glioblastoma. Nat Commun. 2020;11(1):3811.","journal-title":"Nat Commun"},{"issue":"5","key":"3361_CR39","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1172\/JCI126414","volume":"129","author":"Z Chen","year":"2019","unstructured":"Chen Z, Wang HW, Wang S, Fan L, Feng S, Cai X, Peng C, Wu X, Lu J, Chen D, et al. USP9X deubiquitinates ALDH1A3 and maintains mesenchymal identity in glioblastoma stem cells. J Clin Investig. 2019;129(5):2043\u201355.","journal-title":"J Clin Investig"},{"issue":"8","key":"3361_CR40","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41419-021-04000-3","volume":"12","author":"GD Zhu","year":"2021","unstructured":"Zhu GD, Yu J, Sun ZY, Chen Y, Zheng HM, Lin ML, Ou-Yang S, Liu GL, Zhang JW, Shao FM. Genome-wide CRISPR\/Cas9 screening identifies CARHSP1 responsible for radiation resistance in glioblastoma. Cell Death Dis. 2021;12(8):724.","journal-title":"Cell Death Dis"},{"issue":"1\u20132","key":"3361_CR41","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.canlet.2011.12.012","volume":"327","author":"EI Azzam","year":"2012","unstructured":"Azzam EI, Jay-Gerin JP, Pain D. Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury. Cancer Lett. 2012;327(1\u20132):48\u201360.","journal-title":"Cancer Lett"},{"issue":"7239","key":"3361_CR42","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/nature07733","volume":"458","author":"M Diehn","year":"2009","unstructured":"Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature. 2009;458(7239):780\u20133.","journal-title":"Nature"},{"issue":"4","key":"3361_CR43","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.tibs.2014.02.004","volume":"39","author":"I Amelio","year":"2014","unstructured":"Amelio I, Cutruzzola F, Antonov A, Agostini M, Melino G. Serine and glycine metabolism in cancer. Trends Biochem Sci. 2014;39(4):191\u20138.","journal-title":"Trends Biochem Sci"},{"issue":"22","key":"3361_CR44","doi-asserted-by":"publisher","first-page":"6458","DOI":"10.1158\/0008-5472.CAN-16-1730","volume":"76","author":"D Samanta","year":"2016","unstructured":"Samanta D, Semenza GL. Serine synthesis helps hypoxic cancer stem cells regulate redox. Can Res. 2016;76(22):6458\u201362.","journal-title":"Can Res"},{"issue":"12","key":"3361_CR45","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1158\/2159-8290.CD-14-1228","volume":"4","author":"I Martinez-Reyes","year":"2014","unstructured":"Martinez-Reyes I, Chandel NS. Mitochondrial one-carbon metabolism maintains redox balance during hypoxia. Cancer Discov. 2014;4(12):1371\u20133.","journal-title":"Cancer Discov"},{"issue":"6","key":"3361_CR46","doi-asserted-by":"publisher","first-page":"e136098","DOI":"10.1172\/JCI136098","volume":"131","author":"S Osuka","year":"2021","unstructured":"Osuka S, Zhu D, Zhang Z, Li C, Stackhouse CT, Sampetrean O, Olson JJ, Gillespie GY, Saya H, Willey CD, et al. N-cadherin upregulation mediates adaptive radioresistance in glioblastoma. J Clin Invest. 2021;131(6):e136098.","journal-title":"J Clin Invest"},{"issue":"10","key":"3361_CR47","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/nrc.2016.81","volume":"16","author":"M Yang","year":"2016","unstructured":"Yang M, Vousden KH. Serine and one-carbon metabolism in cancer. Nat Rev Cancer. 2016;16(10):650\u201362.","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"3361_CR48","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/ng.890","volume":"43","author":"JW Locasale","year":"2011","unstructured":"Locasale JW, Grassian AR, Melman T, Lyssiotis CA, Mattaini KR, Bass AJ, Heffron G, Metallo CM, Muranen T, Sharfi H, et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet. 2011;43(9):869\u201374.","journal-title":"Nat Genet"},{"issue":"9","key":"3361_CR49","doi-asserted-by":"publisher","first-page":"e153436","DOI":"10.1172\/JCI153436","volume":"132","author":"A D'Avola","year":"2022","unstructured":"D\u2019Avola A, Legrave N, Tajan M, Chakravarty P, Shearer RL, King HW, Kluckova K, Cheung EC, Clear AJ, Gunawan AS, et al. PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma. J Clin Invest. 2022;132(9):e153436.","journal-title":"J Clin Invest"},{"issue":"2","key":"3361_CR50","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41374-021-00666-7","volume":"102","author":"L Jin","year":"2022","unstructured":"Jin L, Kiang KM, Cheng SY, Leung GK. Pharmacological inhibition of serine synthesis enhances temozolomide efficacy by decreasing O(6)-methylguanine DNA methyltransferase (MGMT) expression and reactive oxygen species (ROS)-mediated DNA damage in glioblastoma. Lab Invest. 2022;102(2):194\u2013203.","journal-title":"Lab Invest"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03361-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03361-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03361-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T22:53:45Z","timestamp":1742338425000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-025-03361-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3361"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03361-3","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,19]]},"assertion":[{"value":"12 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Collection and analysis of all clinical GBM samples were approved by the ethics committee of Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology (TJ-IRB20220325). All participants had signed the informed consents. All animal experimentations were approved by the Institutional Review Board of Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology (protocol code TJH-202206015).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approved the final version of the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}